← Eichor
Study identifier: NCT04949633 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Oxytocin vs Prostaglandins for Labor Induction of Women With an Unfavorable Cervix After 24h of Cervical Ripening

Condition: Cervical Ripening · Unfavorable Cervix  ·  Sponsor: University Hospital, Tours

PhasePhase 3
Planned participants1494
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersYes

About this study

Twenty-two percent of deliveries in France are induced. In cases where labor is induced and cervix is unfavorable, cervical ripening prior oxytocin administration is advised in order to reduce the risk of cesarean delivery. Cervical ripening agents, pharmacological (prostaglandins) or mechanical are administered during 24 hours. After 24 hours, most women will be either delivered or in labor but 25% of women will require further induction of labor. For 16% of women who undergo cervical ripening, whatever the cervical ripening method, the cervix remains unchanged after 24 hours. The management of these women is not consensual and depends on the maternity unit where women are cared for. This study seeks to identify the most appropriate strategy for the management of women with an unfavorable cervix after 24 hours of cervical ripening, a strategy which would be associated with the lowest maternal and perinatal morbidity but also with the best maternal satisfaction. Because both strategies are practiced in France, the trial would compare: induction of labor with oxytocin and repeated cervical ripening. The aim is to show that repeating cervical ripening is an unnecessary procedure. And more specifically that oxytocin administration is not associated with a higher caesarean delivery rate and that it reduces the time to delivery in comparison with cervical ripening with prostaglandins.

This description comes directly from the study's public registry record.

Talk to the study team

Caroline DIGUISTO, MD  ·  02 47 47 47 39  ·  carolinediguisto@gmail.com

Always discuss trial participation with your own doctor first.

Locations (14)

Gynaecology-obstetrics, University Hospital, AngersAngers, FranceRecruiting
Gynaecology-obstetrics, University Hospital, BordeauxBordeaux, FranceTerminated
Gynaecology-obstetrics, University Hospital, BrestBrest, FranceRecruiting
Gynaecology-obstetrics, University Hospital, Clermont-FerrandClermont-Ferrand, FranceTerminated
Gynaecology-obstetrics, Hospital St Joseph, MarseilleMarseille, FranceTerminated
Gynaecology-obstetrics, University Hospital, NancyNancy, FranceRecruiting
Gynaecology-obstetrics, University Hospital, NantesNantes, FranceRecruiting
Gynaecology-obstetrics, University Hospital, OrléansOrléans, FranceRecruiting
Gynaecology-obstetrics, Port Royal Maternity Hospital, ParisParis, FranceRecruiting
Gynaecology-obstetrics, University Hospital, PoitiersPoitiers, FranceTerminated
Gynaecology-obstetrics, Hospital, PontoisePontoise, FranceNot Yet Recruiting
Gynaecology-obstetrics, University Hospital, Saint EtienneSaint-Etienne, FranceRecruiting

+ 2 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04949633